Data as of Q4 2025 (Dec 31, 2025)

CME

(CME)

Financial Statements · SEC EDGAR XBRL

Revenue
$6.52B
+6.4%
Net Income
$4.07B
+15.5%
EPS
$11.16
+15.4%
Op. Income
$4.23B
+7.6%
FCF
$4.19B
+16.6%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Operating Income
Non-Operating Income/Expense
Net Income
EPS (Basic)
EPS (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$6.52B
$6.13B
$5.58B
$5.02B
$4.69B
$6.52B
$6.13B
$5.58B
$5.02B
$4.69B
$4.23B
$3.93B
$3.44B
$3.02B
$2.65B
$4.07B
$3.53B
$3.23B
$2.69B
$2.64B
$11.18
$9.69
$8.87
$7.41
$7.30
$11.16
$9.67
$8.86
$7.40
$7.29